Skip to content

Wheelchair Positioning and Neuromuscular Diseases

Wheelchair Positioning and Neuromuscular Diseases Database (Retrospective and Prospective)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05006859
Acronym
BDD-POSIT-MNM
Enrollment
50
Registered
2021-08-16
Start date
2021-05-17
Completion date
2025-12-31
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases

Keywords

Neuromuscular disease, Postural wheelchair disorders, Wheelchair positioning, Pain

Brief summary

This database will describe sitting postural control in wheelchair, as well as PW pain, and pressure ulcers associated with sitting, in patients with neuromuscular disease (NMD).

Detailed description

Neuromuscular diseases are genetic diseases of the muscle or its innervation (nerve connection) causing respiratory, cardiac and especially motor difficulties which may require use of wheelchair. However there is no standardized positioning protocol, so it seems interesting to us to study wheelchair positioning in neuromuscular diseases). The purpose of this study is to describe sitting posture in the wheelchair in patients with neuromuscular disease, pain associated with using the wheelchair, but also to assess the effectiveness of the recommended equipment making the same evaluations in follow-up consultation (a few months after receipt of the prescribed TAP). Posture is assessed by the tool: Measurement of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0), which is a validated tool. Pain is assessed by a Simple Verbal Scale or by a Visual Analog Scale. This database could allow providing guidelines of good practice, for wheelchair positioning for patients with neuromuscular disease.

Interventions

OTHERCohorte

Assessment of postural wheelchair disorders, as well as PW pain, and pressure ulcers associated with sitting

Sponsors

Association Française contre les Myopathies (AFM), Paris
CollaboratorOTHER
Groupement Hospitalier Intercommunal du Vexin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum

Inclusion criteria

: * Patient with neuromuscular disease * Written informed consent (IC) obtained * Adult patients (\> 18 years) Or * Adults under guardianship who has given theirs oral consent and guardian's consent obtained Or * Childs who has given theirs oral consent and parents' consent obtained * Wheelchair user

Exclusion criteria

: • Patient not seen in positioning consultation by N. Pellegrini and / or E. Dupitierr

Design outcomes

Primary

MeasureTime frameDescription
Description of postural wheelchair disorders in the neuromuscular disease populationAt the beginning and the end of the study, an average of 6 monthsMeasurement of Posture by the tool: Measurement of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score (0 = normal, 1 = mild, 2 = moderated and 3 = severe)

Secondary

MeasureTime frameDescription
Comparison of pain associated with using the wheelchairAt the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 monthsAssessment of initial pain (before positioning equipment) and pain after positioning equipment. Pain is assessed by a Simple Verbal Scale or by a Visual Analog Scale (0 to 10) (0 = no pain and 10 is the strongest pain)
Assessment of the incidence of pressure ulcers associated with sitting in NMDAt the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 monthsObservation of the topography and the stage of ulcers associated with sitting
Assessment of the proportion of technical postural aids prescribed for patients who accept the positioning equipmentAt the end of the study, an average of 6 monthsCounts of the numbers of technical postural aids prescribed during consultation
Assessment of the technical postural aids efficacyAt the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 monthsComparison of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score before and after using of technical postural aids (0 = normal, 1 = mild, 2 = moderated and 3 = severe)

Countries

France

Contacts

Primary ContactMaryline Delattre
maryline.delattre@ght-novo.fr+331.30.75.41.31
Backup ContactAudrey Gilibert
audrey.gilibert@ght-novo.fr+331.30.75.40.40

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026